Zydus received FDA approval to conduct a Phase 2b trial testing usnoflast, its oral therapy for ALS, in 210 patients.
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that remains incurable, despite decades of basic and clinical research. Key stakeholders—including the US National ...
WWLP Springfield on MSN1d
Officials approve new Springfield courthouse plansThe Roderick Ireland Courthouse is linked to serious health concerns, five courthouse employees have died of ALS and 60 more ...
Zacks.com on MSN3d
Denali Gains 26.6% in a Year: How Should You Play the Stock?Denali Therapeutics DNLI has performed well in the past 12 months amid a volatile market. Shares of the company have gained ...
The US Food and Drug Administration (FDA) has granted approval for Zydus Lifesciences to proceed with a randomised Phase IIb ...
Ahmedabad: Zydus, a discovery-based, global pharmaceutical company has announced that it has received approval from USFDA to ...
A New Bedford man was sentenced to prison in federal court on Friday for stealing over $450,000 in disability benefits that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback